No Data
No Data
Express News | Pacira BioSciences To Present 104-Week Data Of PCRX-201 For Patients With Mild To Severe Osteoarthritis Of Knee
Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday
Express News | Doma Perpetual - Believes Pacira's Stock Is Undervalued
DOMA Perpetual Supports Pacira's New $300 Million Share Repurchase Authorization as a Meaningful Step to Enhance Value for Shareholders
DOMA Perpetual Supports Pacira's New $300 Million Share Repurchase Authorization As A Meaningful Step To Enhance Value For Shareholders >PCRX
Pacira BioSciences Announces Repurchase Authorization